Profil
Johan Lindh is the founder of Aptahem AB, a company founded in 2014.
He holds the title of Director at Aptahem AB.
Dr. Lindh's current job is at the University of Uppsala, where he started in 2014 and is currently an Associate Professor.
Dr. Lindh obtained a doctorate degree from Imperial College London.
Postes actifs de Johan Lindh
| Sociétés | Poste | Début |
|---|---|---|
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Fondateur | 01/01/2014 |
| University of Uppsala | Corporate Officer/Principal | 01/01/2014 |
Formation de Johan Lindh
| Imperial College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |